Factor V G1691A is associated with an increased risk of retinal vein occlusion: a meta-analysis.

about

Factor V G1691A is associated with an increased risk of retinal vein occlusion: a meta-analysis.

Item

http://www.wikidata.org/entity/Q46010248

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Factor V G1691A is associated ...... in occlusion: a meta-analysis.

@en

Factor V G1691A is associated ...... in occlusion: a meta-analysis.

@nl

type

Item

label

Factor V G1691A is associated ...... in occlusion: a meta-analysis.

@en

Factor V G1691A is associated ...... in occlusion: a meta-analysis.

@nl

prefLabel

Factor V G1691A is associated ...... in occlusion: a meta-analysis.

@en

Factor V G1691A is associated ...... in occlusion: a meta-analysis.

@nl

P1476

Factor V G1691A is associated ...... in occlusion: a meta-analysis.

@en

P2093

Jingyi Zhang

http://www.w3.org/2001/XMLSchema#string

Xi Zhang

http://www.w3.org/2001/XMLSchema#string

Xiangning Ji

http://www.w3.org/2001/XMLSchema#string

Yuanyuan Zou

http://www.w3.org/2001/XMLSchema#string

Yuqing Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion

Thrombophilia: genetic polymorphisms and their association with retinal vascular occlusive disease

Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis.

Activated protein C resistance in patients with central retinal vein occlusion.

Retinal Vein Occlusion.

Central retinal vein occlusion: modifying current treatment protocols.

Retinal vascular occlusion: a window to diagnosis of familial and acquired thrombophilia and hypofibrinolysis, with important ramifications for pregnancy outcomes.

Factor V Leiden.

Investigational drugs for retinal vein occlusion.

P304

75467-75477

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.20636

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29088882

http://www.w3.org/2001/XMLSchema#string

P932

5650437

http://www.w3.org/2001/XMLSchema#string